Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein

JAMA Neurology

Volumn 72, Issue 8, 2015, Pages 882-888

  Gershen, Leah D ^a   Zanotti Fregonara, Paolo ^a,b   Dustin, Irene H ^c   Liow, Jeih San ^a   Hirvonen, Jussi ^d   Kreisl, William C ^a   Jenko, Kimberly J ^a   Inati, Sara K ^c   Fujita, Masahiro ^a   Morse, Cheryl L ^a   Brouwer, Chad ^a   Hong, Jinsoo S ^a   Pike, Victor W ^a   Zoghbi, Sami S ^a   Innis, Robert B ^a   Theodore, William H ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; DPA 713 C 11; PBR28 C 11; RADIOISOTOPE; RADIOLIGAND; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; TSPO PROTEIN, HUMAN;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BINDING AFFINITY; BRAIN ASYMMETRY; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ENTORHINAL CORTEX; FEMALE; FUSIFORM GYRUS; HIPPOCAMPAL SCLEROSIS; HUMAN; ISOTOPE LABELING; MALE; NERVOUS SYSTEM INFLAMMATION; PARAHIPPOCAMPAL GYRUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOCHEMISTRY; TEMPORAL CORTEX; TEMPORAL LOBE EPILEPSY; BRAIN; INFLAMMATION; METABOLISM; MIDDLE AGED; SCINTISCANNING; YOUNG ADULT;

ADULT; BRAIN; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RECEPTORS, GABA; YOUNG ADULT;

EID: 84938926963     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.0941     Document Type: Article

References (31)

1. Aronica E, Ravizza T, Zurolo E, Vezzani A. Astrocyte immune responses in epilepsy. Glia. 2012; 60(8):1258-1268.
2. Librizzi L, Noè F, Vezzani A, de Curtis M, Ravizza T. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol. 2012;72(1):82-90.
3. Ravizza T, Vezzani A. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience. 2006;137(1):301-308.
4. Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2008;29(1): 142-160.
5. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7 (1):31-40.
6. Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010;16(4):413-419.
7. Crespel A, Coubes P, Rousset M-C, et al. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res. 2002;952(2):159-169.
8. Iyer A, Zurolo E, Spliet WGM, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia. 2010;51(9): 1763-1773.
9. Ravizza T, Boer K, Redeker S, et al. The IL-1β system in epilepsy-associated malformations of cortical development. Neurobiol Dis. 2006;24(1): 128-143.
10. Zurolo E, Iyer A, Maroso M, et al. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain. 2011; 134(pt 4):1015-1032.
11. Ravizza T, Noé F, Zardoni D, Vaghi V, Sifringer M, Vezzani A. Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1β production. Neurobiol Dis. 2008; 31(3):327-333.
12. Pernot F, Heinrich C, Barbier L, et al. Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. Epilepsia. 2011;52(12): 2315-2325.
13. Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118(1):1-17.
14. Dedeurwaerdere S, Callaghan PD, Pham T, et al. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Res. 2012;2(1):60.
15. Johnson EW, de Lanerolle NC, Kim JH, et al. "Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology. 1992;42(4):811-815.
16. Kreisl WC, Lyoo CH, McGwier M, et al; Biomarkers Consortium PET Radioligand Project Team. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. Brain. 2013;136(pt 7):2228-2238.
17. Hirvonen J, Kreisl WC, Fujita M, et al. Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med. 2012;53(2):234-240.
18. Boutin H, Chauveau F, Thominiaux C, et al. 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation. J Nucl Med. 2007;48(4):573-581.
19. Endres CJ, Pomper MG, James M, et al. Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. J Nucl Med. 2009;50(8):1276-1282.
20. Owen DRJ, Gunn RN, Rabiner EA, et al. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med. 2011;52(1): 24-32.
21. Butler T, Ichise M, Teich AF, et al. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging. 2013;23(1):129-131.
22. Banati RB, Goerres GW, Myers R, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 1999;53(9): 2199-2203.
23. Kreisl WC, Jenko KJ, Hines CS, et al; Biomarkers Consortium PET Radioligand Project Team. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab. 2013;33(1):53-58.
24. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533-1539.
25. Theodore WH, Giovacchini G, Bonwetsch R, et al. The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography. Epilepsia. 2006;47(3):499-503.
26. Owen DR, Guo Q, Kalk NJ, et al. Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study. J Cereb Blood Flow Metab. 2014;34(6):989-994.
27. Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun. 2008;22(6):797-803.
28. Aronica E, Boer K, van Vliet EA, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis. 2007;26(3): 497-511.
29. Kim SY, Buckwalter M, Soreq H, Vezzani A, Kaufer D. Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis. Epilepsia. 2012;53(suppl 6):37-44.
30. Bauer B, Hartz AMS, Pekcec A, Toellner K, Miller DS, Potschka H. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol. 2008;73(5):1444-1453.
31. Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5): 311-318.